Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mao Liu

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Frontiers in Epidemiology|March 8, 2024
The rising death burden of atrial fibrillation and flutter in low-income regions and younger populationsYe-Mao Liu, Wenxin Wang, Xingyuan Zhang, et al.
World Journal of Clinical Cases|December 21, 2020
No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19Jiang-Hua Zhou, Bin Wu, Wen-Xin Wang, et al.
Public Health Nutrition|September 23, 2022
The global disease burden attributable to a diet low in fibre in 204 countries and territories from 1990 to 2019Ming Zhuo, Ze Chen, Mao-Lin Zhong, et al.
Nature Medicine|June 20, 2020
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsQuan-Xin Long, Xiao-Jun Tang, Qiu-Lin Shi, et al.
Frontiers in Endocrinology|February 28, 2022
High Remnant Cholesterol Level Potentiates the Development of HypertensionMing-Ming Chen, Xuewei Huang, Chengsheng Xu, et al.
Cell Metabolism|September 3, 2021
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart diseaseWenxin Wang, Manli Hu, Hui Liu, et al.
Frontiers in Endocrinology|October 14, 2022
The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in ChinaFang Lei, Juan-Juan Qin, Xiaohui Song, et al.
Med (New York, N.Y.)|October 12, 2020
Kidney Function Indicators Predict Adverse Outcomes of COVID-19Ye-Mao Liu, Jing Xie, Ming-Ming Chen, et al.
Hypertension (Dallas, Tex. : 1979)|June 5, 2020
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 MortalityFeng Zhou, Ye-Mao Liu, Jing Xie, et al.
Cell Metabolism|August 31, 2020
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 DiabetesXu Cheng, Ye-Mao Liu, Haomiao Li, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Frontiers in Epidemiology|March 8, 2024
The rising death burden of atrial fibrillation and flutter in low-income regions and younger populationsYe-Mao Liu, Wenxin Wang, Xingyuan Zhang, et al.
World Journal of Clinical Cases|December 21, 2020
No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19Jiang-Hua Zhou, Bin Wu, Wen-Xin Wang, et al.
Public Health Nutrition|September 23, 2022
The global disease burden attributable to a diet low in fibre in 204 countries and territories from 1990 to 2019Ming Zhuo, Ze Chen, Mao-Lin Zhong, et al.
Nature Medicine|June 20, 2020
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsQuan-Xin Long, Xiao-Jun Tang, Qiu-Lin Shi, et al.
Frontiers in Endocrinology|February 28, 2022
High Remnant Cholesterol Level Potentiates the Development of HypertensionMing-Ming Chen, Xuewei Huang, Chengsheng Xu, et al.
Cell Metabolism|September 3, 2021
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart diseaseWenxin Wang, Manli Hu, Hui Liu, et al.
Frontiers in Endocrinology|October 14, 2022
The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in ChinaFang Lei, Juan-Juan Qin, Xiaohui Song, et al.
Med (New York, N.Y.)|October 12, 2020
Kidney Function Indicators Predict Adverse Outcomes of COVID-19Ye-Mao Liu, Jing Xie, Ming-Ming Chen, et al.
Hypertension (Dallas, Tex. : 1979)|June 5, 2020
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 MortalityFeng Zhou, Ye-Mao Liu, Jing Xie, et al.
Cell Metabolism|August 31, 2020
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 DiabetesXu Cheng, Ye-Mao Liu, Haomiao Li, et al.
Pageof 26